Skip to content
RDL Network logo
Analysis of clinical and molecular profiles of patients with innate resistance to ANTI-PD-1 +/- ANTI-CTLA-4 immunotherapy in metastatic melanoma — Tuba N. Gide (2021) | RDL Network